Zynerba Pharmaceuticals Inc reports Q2 results and provides operational update

Zynerba Pharmaceuticals (NASDAQ:ZYNE) Inc has reported financial results for the second quarter ended June 30, 2022, and provided an overview of its recent...

Related Keywords

Armando Anido ,Zynerba Pharmaceuticals ,Drug Administration ,New Drug Application ,Fragilex Conference ,American Society ,Clinical Psychopharmacology Annual Meeting ,Social Avoidance ,Autism Spectrum Disorder ,